Semaglutide, a GLP-1 receptor agonist, works on the same brain regions affected by hormonal shifts, making it a potential option for women navigating midlife weight challenges
What it does is: Lower blood sugar levels Alow gastric emptying Reduce appetite Treat type 2 diabetes Weight loss Semaglutide is FDA-approved for type 2 diabetes, while compounded versions lack standardized clinical trials
Am J Physiol Heart Circ Physiol 291:H239H250
If people want to ask medical questions unrelated to the Newsletters or Podcasts, they either need to become paying subscribers or email ([email protected]) to request a complimentary subscription
Research shows oxytocin reduces symptoms across multiple anxiety-related conditions: generalized anxiety, social anxiety, OCD, and depression with anxious features
In addition, some pharmacies have explored using pharmacist prescribing for weight management as part of the NHS England pathfinder programme